Interactions between nanoparticles and lymphatic systems: Mechanisms and applications in drug delivery

被引:13
作者
Tang, Yisi [1 ,2 ,3 ,4 ]
Liu, Bao [1 ,2 ]
Zhang, Yuting [1 ,2 ]
Liu, Yuling [1 ,2 ]
Huang, Yongzhuo [1 ,5 ,6 ,7 ]
Fan, Wufa [1 ,2 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Bioact Subst & Funct Nat Med, Inst Mat Med, Beijing 100050, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, Beijing Key Lab Drug Delivery Technol & Novel Form, Beijing 100050, Peoples R China
[3] Chinese Acad Med Sci, Inst Lab Anim Sci, NHC Key Lab Comparat Med, Natl Ctr Technol Innovat Anim Model, Beijing 100021, Peoples R China
[4] Peking Union Med Coll, Comparat Med Ctr, Beijing 100021, Peoples R China
[5] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
[6] Chinese Acad Sci, Zhongshan Inst Drug Discovery, Shanghai Inst Mat Med, Zhongshan 528437, Peoples R China
[7] NMPA Key Lab Qual Res & Evaluat Pharmaceut Excipie, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
Lymphatic system; Lymphatic delivery system; Lymph node; Protein corona; Dendritic cell; Vaccine; LIPID-BASED FORMULATIONS; DENDRITIC CELLS; SUBCUTANEOUS INJECTION; ORAL DELIVERY; TRANSPORT; NODE; ACID; ABSORPTION; LIPOSOMES; EXPOSURE;
D O I
10.1016/j.addr.2024.115304
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The lymphatic system has garnered significant attention in drug delivery research due to the advantages it offers, such as enhancing systemic exposure and enabling lymph node targeting for nanomedicines via the lymphatic delivery route. The journey of drug carriers involves transport from the administration site to the lymphatic vessels, traversing the lymph before entering the bloodstream or targeting specific lymph nodes. However, the anatomical and physiological barriers of the lymphatic system play a pivotal role in influencing the behavior and efficiency of carriers. To expedite research and subsequent clinical translation, this review begins by introducing the composition and classification of the lymphatic system. Subsequently, we explore the routes and mechanisms through which nanoparticles enter lymphatic vessels and lymph nodes. The review further delves into the interactions between nanomedicine and body fluids at the administration site or within lymphatic vessels. Finally, we provide a comprehensive overview of recent advancements in lymphatic delivery systems, addressing the challenges and opportunities inherent in current systems for delivering macromolecules and vaccines.
引用
收藏
页数:20
相关论文
共 173 条
  • [51] Immunogenicity Challenges Associated with Subcutaneous Delivery of Therapeutic Proteins
    Jarvi, Nicole L.
    Balu-Iyer, Sathy V.
    [J]. BIODRUGS, 2021, 35 (02) : 125 - 146
  • [52] Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications
    Jeong, Michaela
    Lee, Yeji
    Park, Jeongeun
    Jung, Hyein
    Lee, Hyukjin
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2023, 200
  • [53] Oral delivery of topotecan in polymeric nanoparticles: Lymphatic distribution and pharmacokinetics
    Jeong, Seung-Hyun
    Jang, Ji-Hun
    Lee, Yong-Bok
    [J]. JOURNAL OF CONTROLLED RELEASE, 2021, 335 : 86 - 102
  • [54] Lymph Node Delivery Strategy Enables the Activation of Cytotoxic T Lymphocytes and Natural Killer Cells to Augment Cancer Immunotherapy
    Jiang, Dandan
    Gao, Tong
    Liang, Shuang
    Mu, Weiwei
    Fu, Shunli
    Liu, Yang
    Yang, Rui
    Zhang, Zipeng
    Liu, Yongjun
    Zhang, Na
    [J]. ACS APPLIED MATERIALS & INTERFACES, 2021, 13 (19) : 22213 - 22224
  • [55] Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA
    Jiang, Ge
    Park, Kitae
    Kim, Jiseok
    Kim, Ki Su
    Oh, Eun Ju
    Kang, Hyungu
    Han, Su-Eun
    Oh, Yu-Kyoung
    Park, Tae Gwan
    Hahn, Sei Kwang
    [J]. BIOPOLYMERS, 2008, 89 (07) : 635 - 642
  • [56] Chiral-Selective Antigen-Presentation by Supramolecular Chiral Polymer Micelles
    Jiang, Hejin
    Liu, Rui
    Wang, Lu
    Wang, Xinyue
    Zhang, Mengmeng
    Lin, Sisi
    Cao, Zhenping
    Wu, Feng
    Liu, Yingbin
    Liu, Jinyao
    [J]. ADVANCED MATERIALS, 2023, 35 (05)
  • [57] Long-acting parenteral drug delivery systems for the treatment of chronic diseases
    Jindal, Anil B.
    Bhide, Atharva R.
    Salave, Sagar
    Rana, Dhwani
    Benival, Derajram
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2023, 198
  • [58] Cross-presentation by dendritic cells
    Joffre, Olivier P.
    Segura, Elodie
    Savina, Ariel
    Amigorena, Sebastian
    [J]. NATURE REVIEWS IMMUNOLOGY, 2012, 12 (08) : 557 - 569
  • [59] Nanotargeted Delivery of Immune Therapeutics in Type 1 Diabetes
    Jung, Sungwook
    Ben Nasr, Moufida
    Bahmani, Baharak
    Usuelli, Vera
    Zhao, Jing
    Sabiu, Gianmarco
    Seelam, Andy Joe
    Naini, Said Movahedi
    Balasubramanian, Hari Baskar
    Park, Youngrong
    Li, Xiaofei
    Khalefa, Salma Ayman
    Kasinath, Vivek
    Williams, MacKenzie D.
    Rachid, Ousama
    Haik, Yousef
    Tsokos, George C.
    Wasserfall, Clive H.
    Atkinson, Mark A.
    Bromberg, Jonathan S.
    Tao, Wei
    Fiorina, Paolo
    Abdi, Reza
    [J]. ADVANCED MATERIALS, 2023, 35 (40)
  • [60] Transcytosis route mediates rapid delivery of intact antibodies to draining lymph nodes
    Kahari, Laura
    Fair-Makela, Ruth
    Auvinen, Kaisa
    Rantakari, Pia
    Jalkanen, Sirpa
    Ivaska, Johanna
    Salmi, Marko
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (08) : 3086 - 3102